hsa-miR-6875-5p
Submitted by Anonymous on Wed, 10/30/2019 - 22:16
Pubmed
Gene symble | Title | PMID | Curated descirption | Category | Literature category |
---|---|---|---|---|---|
hsa-miR-6875-5p | Novel combination of serum microRNA for detecting breast cancer in the early stage | 26749252 | MiRNA expressions were compared between patients with breast cancer and non‐breast cancer, and a combination of five miRNA (miR‐1246, miR‐1307‐3p, miR‐4634, miR‐6861‐5p and miR‐6875‐5p) was found to be able to detect breast cancer | biomarker | BC/OC research |
hsa-miR-6875-5p | MicroRNA-6826 and 6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer | 27878288 | Although further clarification is needed regarding the functions of miR-6826 and miR-6875 and their relationship to immune-related molecules, plasma miR-6826 and miR-6875 may be useful negative biomarkers for predicting the efficacy of vaccine treatment | biomarker | BC/OC research |
hsa-miR-6875-5p | Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery | 30976046 | Using microarray analysis, we successfully identified six specific miRNAs (miR-1225-3p, miR-1234-3p, miR1260b, miR-1470, miR-6834-3p, and miR-6875-5p) associated with recurrence and prognosis of BTC after radical surgery | biomarker | BC/OC research |
Survival analysis